Abstract: A fuel cell vehicle and associated fluid line arrangement include a main branch, which passes through a fuel cell unit, and a secondary branch that branches off the main branch and includes a flow limiter having a tube element, the internal cross section of which decreases downstream with respect to a flow direction, and a piston element moveable at least partially downstream along a movement path in the tube element counter to a restoring force between an open position and a restricting position. The flow limiter provides a fluid-carrying cross section of passage that is smaller than in the open position formed between the piston element and the tube element to limit mass flow through the secondary branch between a maximum and minimum mass flow.

Abstract: A component for producing building parts has two outer parts arranged at a distance from one another and at least one inner part arranged between the outer parts. The inner part has at least one first part adjacent to an outer part and a second part adjacent to the upper outer part, which has at least one vibration-capable leg, which projects from a third part connecting the first part to the second part, is spaced from the first part by at least one slot and on its side facing away from the first part has at least one recess, which is bridged by the upper outer part and delimited at one end by a projection that has a contact surface, on which the upper outer part is mounted, so that an overall vibration-capable mounting results for the one outer part, leading to a decoupling of structure-borne sound.

Abstract: A charging device for a primary vehicle configured for charging a secondary vehicle comprises at least one repositionable coupling element. The at least one coupling element is repositionable such that it can be positioned correspondingly in relation to a coupling element of a charging device of the secondary vehicle. The charging device is set up to ensure an inductive charging process between the primary vehicle and the secondary vehicle using the coupling element.

Abstract: The invention refers to a device for inhibiting the neural activity of a carotid sinus nerve (CSN) or carotid body of a subject, the device comprising: one or more transducers configured to apply a signal to the CSN or associated carotid body of the subject, optionally at least two such transducers; and a controller coupled to the one or more transducers, the controller controlling the signal to be applied by the one or more transducers, such that the signal inhibits the neural activity of the CSN or carotid body to produce a physiological response in the subject, wherein the physiological response is one or more of the group consisting of: an increase in insulin sensitivity in the subject, an increase in glucose tolerance in the subject, a decrease in (fasting) plasma glucose concentration in the subject, a reduction in subcutaneous fat content in the subject, and a reduction in obesity in the subject.

Abstract: The invention refers to a device for inhibiting the neural activity of a carotid sinus nerve (CSN) or carotid body of a subject, the device comprising: one or more transducers configured to apply a signal to the CSN or associated carotid body of the subject, optionally at least two such transducers; and a controller coupled to the one or more transducers, the controller controlling the signal to be applied by the one or more transducers, such that the signal inhibits the neural activity of the CSN or carotid body to produce a physiological response in the subject, wherein the physiological response is one or more of the group consisting of: an increase in insulin sensitivity in the subject, an increase in glucose tolerance in the subject, a decrease in (fasting) plasma glucose concentration in the subject, a reduction in subcutaneous fat content in the subject, and a reduction in obesity in the subject.

Abstract: Modulation of neural activity in the superior laryngeal nerve (SLN) or cervical sympathetic trunk (CST) is effective in treating diseases and conditions mediated by thyroid and parathyroid hormones, in particular diseases associated with calcitonin secretion (e.g. osteoporosis) or diseases associated with thyroxine secretion (e.g. hypothyroid syndrome).

Abstract: The invention provides devices, apparatuses, systems and methods for treating and ameliorating inflammation of the gut. In particular, the invention provides devices, apparatuses and methods in which a neuromodulatory signal is delivered a splenic nerve and/or superior mesenteric plexus (SMP). The signal is able to treat inflammatory disorders, e.g., colitis, for example in Inflammatory Bowel Disease.

Abstract: The invention provides devices, apparatuses, systems and methods for treating and ameliorating inflammation of the gut. In particular, the invention provides devices, apparatuses and methods in which a neuromodulatory signal is delivered a splenic nerve and/or superior mesenteric plexus (SMP). The signal is able to treat inflammatory disorders, e.g., colitis, for example in Inflammatory Bowel Disease.

Abstract: The present invention relates to the use of a composition as a fungicide, wherein said composition comprises at least one compound of formula (I) or formula (II) wherein wherein R2, R3, R4, R5, R6 and R7 are independently of each other H, OH or OCH3.

Abstract: Methods for treating polycystic ovarian syndrome with a neuromodulation device that modulates sympathetic neural activity are described herein. The neuromodulation device is an apparatus for the treatment of polycystic ovarian syndrome. In one aspect, the apparatus decreases the neural activity of a postganglionic ovary-innervating sympathetic nerve. Modulation in neural activity may be achieved using an apparatus comprising one or more stimulators each configured to apply a signal to a postganglionic ovary-innervating sympathetic nerve of the patient, a controller coupled to the one or more stimulators, the controller controlling the signal to be applied by each of the one or more stimulators, such that the signal decreases the neural activity of the nerve to produce a physiological and/or biochemical response in the patient, wherein the physiological and/or biochemical response comprises an improvement in one or more symptoms of polycystic ovarian syndrome.

Abstract: Modulation of neural activity in the superior laryngeal nerve (SLN) or cervical sympathetic trunk (CST) is effective in treating diseases and conditions mediated by thyroid and parathyroid hormones, in particular diseases associated with calcitonin secretion (e.g. osteoporosis) or diseases associated with thyroxine secretion (e.g. hypothyroid syndrome).

Abstract: The present invention relates to the use of a composition as a fungicide, wherein said composition comprises at least one compound of formula (I) or formula (II), wherein R1=formula (IV) or Formula (V), wherein R2, R3, R4; R5, R6 and R7 are independently of each other H, OH or OCH3.

Abstract: The present invention provides improved devices, systems and methods to provide for control of bladder function. Aspects of the present disclosure relate to an apparatus, system and/or a method for modulating the neural activity of afferent fibres of the pelvic nerve to bladder function. In one aspect, the disclosure relates to the use of pharmaceutical compositions in patients undergoing neuromodulation therapy.

Abstract: The invention provides devices, apparatuses, systems and methods for treating and ameliorating inflammation of the gut. In particular, the invention provides devices, apparatuses and methods in which a neuromodulatory signal is delivered a splenic nerve and/or superior mesenteric plexus (SMP). The signal is able to treat inflammatory disorders, e.g., colitis, for example in Inflammatory Bowel Disease.

Abstract: The present invention relates to medical devices and, more particularly, to medical devices that deliver neuromodulating therapy.

Abstract: The invention refers to a device for inhibiting the neural activity of a carotid sinus nerve (CSN) or carotid body of a subject, the device comprising: one or more transducers configured to apply a signal to the CSN or associated carotid body of the subject, optionally at least two such transducers; and a controller coupled to the one or more transducers, the controller controlling the signal to be applied by the one or more transducers, such that the signal inhibits the neural activity of the CSN or carotid body to produce a physiological response in the subject, wherein the physiological response is one or more of the group consisting of: an increase in insulin sensitivity in the subject, an increase in glucose tolerance in the subject, a decrease in (fasting) plasma glucose concentration in the subject, a reduction in subcutaneous fat content in the subject, and a reduction in obesity in the subject.

Abstract: This invention relates to a data system that anonymizes personalized event data, by receiving the personalized event data containing an encrypted personal identifier and determining whether an entry exists for the encrypted personal identifier in a key database. The encrypted personal identifier may be associated with a system identifier that uniquely identifies the encrypted personal identifier and is uniquely associated to one system identifier. If no entry is detected in the key database for the received encrypted personal identifier, then a new entry for the key database is generated in which the received encrypted personal identifier is uniquely associated to a new system identifier.

Abstract: This invention relates to a data system that anonymizes personalized event data, by receiving the personalized event data containing an encrypted personal identifier and determining whether an entry exists for the encrypted personal identifier in a key database. The encrypted personal identifier may be associated with a system identifier that uniquely identifies the encrypted personal identifier and is uniquely associated to one system identifier. If no entry is detected in the key database for the received encrypted personal identifier, then a new entry for the key database is generated in which the received encrypted personal identifier is uniquely associated to a new system identifier.

Abstract: The disclosure relates to a photovoltaic element having a sealing web with at least one photovoltaic module which is mounted on one side of the sealing web and has contact points and electrical connections. The contact points of the photovoltaic module can be arranged on a side facing the sealing web, and the electrical connections can pass through the sealing web.

Abstract: The invention is directed to two coupled vehicles (1) such as railbound vehicles or articulated busses, with a connection with at least one bellows (2) as well as with a coupling device comprising two coupling frames (4, 5), said coupling frames (4, 5) comprising interengaging male and female coupling members (10, 15), a locking member (30) being provided for respectively locking the male coupling members (15) in the female coupling members (10), said locking member (30) being slidably guided by the respective locking member (4, 5), said locking member (30) communicating with a force transmitting member (9) that is slidably guided in the respective one of the coupling frames (4, 5), the force transmitting member (9) transmitting both tensile and shear forces.